Contact

Partners & Collaborators

JPT Peptide Technologies is an established partner in research projects worldwide. Our network combines partners within universities, research organizations and industry that value JPT’s unmatched peptide synthesis power, R&D specialists and high quality standards according to DIN ISO 9001:2015 certification and GCLP regulations. 

JPT offers its services and contract research and development project participation in flexible business arrangements.

Our Business Models are:

  • Fee-for-service projects
  • FTE based and milestone driven collaboration projects
  • Shared risk, partnered development projects
  • Participation on publicly granted R&D projects (SME qualification)

Our Track Record

JPT has run several successful projects in different scientific fields:

Immunotherapy & Vaccines

  • Peptide selection and synthesis for individualized neo-epitope based vaccination strategies
  • Peptide pool design and synthesis for adoptive cell transfer therapy
  • Design of comprehensive peptide libraries for companion diagnostics and treatment
  • Identification of serological predictive, prognostic, and surrogate biomarkers
  • Proteome-spanning vaccine target discovery
  • Deep T-cell epitope discovery

Proteomics

  • Development of next generation standards for targeted proteomics
  • Characterization of specificity profiles for proteins and protein families
  • Design and synthesis of peptide libraries for proteome wide detection and quantification of proteins
  • Development of molecular probes for the multiplexed detection and quantification of proteins from biological samples
  • Discovery of proteotypic peptide markers for functional proteomics
  • Identification of epigenetic states of proteins and characterization of enzymatic alterations

Drug Discovery

  • Design and production of screening libraries, peptides and peptidomimetics
  • Identification and optimization of agonistic and antagonistic ligands
  • Identification and optimization of affinity ligands
  • Identification and optimization of stabilizing peptides as excipients
  • Development of surrogate bioassays for antigen-free detection of therapeutic protein
  • Substrate identification and optimization for several orphan enzymes for screening assays

Partners

Stay in touch and be the first to receive the latest news!